Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 4/2001

01-04-2001 | Original Article

A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A

Authors: Mirte M. Malingré, Jos H. Beijnen, Hilde Rosing, Franciska J. Koopman, Olaf van Tellingen, Ken Duchin, Wim W. Ten Bokkel Huinink, Martha Swart, Jan Lieverst, Jan H.M. Schellens

Published in: Cancer Chemotherapy and Pharmacology | Issue 4/2001

Login to get access
Metadata
Title
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
Authors
Mirte M. Malingré
Jos H. Beijnen
Hilde Rosing
Franciska J. Koopman
Olaf van Tellingen
Ken Duchin
Wim W. Ten Bokkel Huinink
Martha Swart
Jan Lieverst
Jan H.M. Schellens
Publication date
01-04-2001
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 4/2001
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800000226

Other articles of this Issue 4/2001

Cancer Chemotherapy and Pharmacology 4/2001 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine